3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
12
Small Cell Lung Carcinoma
11
Fallopian Tube Neoplasms
9
Neuroblastoma
6
Neoplasm Metastasis
3
Lung Neoplasms
3
Ganglioneuroblastoma
3
Carcinoma, Ovarian Epithelial
3
Uterine Cervical Neoplasms
2
Sarcoma, Ewing
2
Rhabdoid Tumor
2
Recurrence
2
Leukemia, Myeloid, Acute
2
Glioma
2
Central Nervous System Neoplasms
2
Wilms Tumor
1
Thrombocythemia, Essential
1
SCLC
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Pleuropulmonary blastoma
1
Peritoneal Neoplasms
1
Pediatric Brain Tumor
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Neoplasms
1
Myelodysplastic-Myeloproliferative Diseases
1
Lymphoma, Follicular
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Interventions
Injections
3
Cytarabine
3
pegylated granulocyte colony-stimulating factor
2
Decitabine
2
Daunorubicin
2
Cladribine
2
Biopsy
2
Azacitidine
2
venetoclax
1
ruxolitinib
1
fludarabine phosphate
1
fedratinib
1
enasidenib
1
Whole-Body Irradiation
1
Tacrolimus
1
Spinal Puncture
1
Specimen Handling
1
Peripheral Blood Stem Cell Transplantation
1
Mycophenolic Acid
1
Mitoxantrone
1
Liposomes
1
Gemtuzumab
1
Cyclophosphamide
1
CPX-351
1
Bone Marrow Transplantation
1
2'-chloro-2'-deoxyadenosine
1
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Monocytic, Acute
×
Topotecan
×
90 days
×
Clear all
No trials found.